Meeting
2017 Genitourinary Cancers Symposium
Determinants of treatment in patients with stage IV renal cell carcinoma.
Authors
Christopher S. Hollenbeak
Departments of Surgery and Public Health Sciences, Penn State College of Medicine, Hershey, PA
Christopher S. Hollenbeak , Eric W. Schaefer , Justin Doan , Jay D. Raman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer
Track
Renal Cell Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 486)
DOI
10.1200/JCO.2017.35.6_suppl.486
Abstract #
486
Poster Bd #
F1
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Pancreatic metastases from renal cell carcinoma: Prognostic relevance and outcome in patients treated with targeted agents.
First Author: Paolo Grassi
Poster
2015 Genitourinary Cancers Symposium
Prognosis and outcome of patients with pancreatic metastases from renal cell carcinoma: When the site matters.
First Author: Paolo Grassi
Poster
2022 ASCO Genitourinary Cancers Symposium
Systemic therapy in patients with metastatic Xp11.2 translocation renal cell carcinoma.
First Author: Xieqiao Yan
Poster
2021 Gastrointestinal Cancers Symposium
Treatment patterns and survival in patients with late-stage hepatocellular carcinoma in France: A retrospective database analysis.
First Author: Jean-frederic Blanc